The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...

I’m , The Globe’s new health and wellness reporter. Every day my inbox is flooded with people trying to sell me on new ways ...

The DEA has announced new rules for remote prescription of controlled substances. As telehealth adoption grows, regulatory ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.

College students who spent a little bit of free time each week interacting with therapy dogs on campus during their first ...